Search results
Sunquick orange concentrate manufacturer rejects claims product can be used to treat cough
AFP via Yahoo News· 3 days agoThe manufacturer of a popular orange concentrate beverage in Malaysia has rejected claims its...
Gateway - Quartz
Quartz· 7 days agoA federal judge blocked low-cost carrier JetBlue’s $3.8 billion takeover of ultra-low-cost carrier Spirit Airlines this week, putting the smaller airline’s future in jeopardy. The Bill & Melinda ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 3 days agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 5 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both...
Morningstar· 4 days agoJohnson & Johnson (NYSE: JNJ) today announced positive topline results from the pivotal Phase 3 GRAVITI investigational study of TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in ...
Mubadala Investment Co PJSC Makes New $53.93 Million Investment in Evotec SE (NASDAQ:EVO)
ETF DAILY NEWS· 7 days agoMubadala Investment Co PJSC bought a new position in Evotec SE (NASDAQ:EVO – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought 4,597,701 shares of the company’s stock ...
Pages from the Past
La Crosse Tribune· 4 days agoWith better conditions of late, tobacco plants have come along rapidly and tobacco planting is now on in earnest. Readstown, June 16 – Flags were...
Gross-tasting medications can be a barrier to treatment. Philly researchers developed a 'bitter...
New Hampshire Union Leader· 6 days agoPeihua Jiang knows how difficult it can be to convince a child to take a sip of a bitter liquid...
Qiagen Lays out Four-Year Plan to Achieve 7 Percent CAGR
GenomeWeb News· 5 days agoExecutives at the event asserted that Qiagen would drive growth through sales in its three fastest-growing businesses — digital PCR, syndromic testing, and bioinformatics — while also expanding ...
This Startup Claimed Its Blood Transfusions Could Reverse Aging. Then, the FDA Stepped In
Popular Mechanics· 2 days agoFROM VAMPIRES TO VAMPIRE FACIALS, humans have always been intrigued by young blood—and its potential...
